Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at whether ML-007C-MA can help people with Psychosis Associated With Alzheimer's Disease. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether Acute (24-hour) abstinence can help people with Acute Abstinence From Cigarettes vs E-cigarettes. Participants take part in Acute (24-hour) abstinence and complete follow-up assessments.
This study is looking at whether a digital support tool can help people with Treatment-resistant Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at care and outcomes for people with Schizophrenia or schizoaffective disorder. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether Intervention Arm: Hatha Yoga can help people with SCHIZOPHRENIA 1 or Hospitalized. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at whether 14C-SEP-380135 can help people with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This observational study is following people with Methamphetamine Use Disorder or Methamphetamine-induced Psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with schizoaffective disorder to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at investigate the early sensory system in clinical high risk (CHR), first episode psychosis (FEP) individuals and heathly controls for people with Early Psychosis or Schizophrenia Prodromal. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is comparing NBI-1117570 with placebo for people with Schizophrenia. Participants receive NBI-1117570 or placebo and complete study visits and assessments.
This study is looking at whether a digital support tool can help people with Psychosis or Schizophrenia Disorder. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether a digital support tool can help people with psychosis. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at be the first to take a deep look at cognitive function over a full year of XT treatment for people with Schizophrenia, Psychosis, or Cognitive Impairment. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether Acceptance and Commitment Therapy (ACT-SC) can help people with Smoking Cessation or Schizophenia Disorder. Participants take part in Acceptance and Commitment Therapy (ACT-SC) and complete follow-up assessments.
This study is comparing high-frequency transcranial alternating current stimulation with sham-treatment arm for people with Schizophrenia. Participants receive high-frequency transcranial alternating current stimulation or sham-treatment arm and complete study visits and assessments.
This study is looking at whether Cannabidiol (CBD) can help people with Clinical High Risk for Psychosis or Clinical High Risk for Developing Psychosis. Participants take part in Cannabidiol (CBD) and complete follow-up assessments.
This study is looking at whether VR-assisted occupational training can help people with Schizophrenia or Cognitive Impairment. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at whether Intracranial electrodes can help people with Schizophrenia Disorders, Mental Disorder, or psychosis. Participants take part in Intracranial electrodes and complete follow-up assessments.
This study is looking at whether an online mindfulness program can help people with Schizophrenia Disorder, Schizoaffecitve Disorder, or Aggression. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether Normobaric Oxygen can help people with Psychosis, Schizophrenia, or First-episode Psychosis. Participants take part in Normobaric Oxygen and complete follow-up assessments.
This study is looking at evaluate the long-term outcomes among individuals participating in this clinical service for people with Prodromal Schizophrenia. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is comparing 3 Minute iTBS to the L DLPFC with Precision Brain Stimulation for Cannabis Users with Healthy Controls for people with Cannabis Use, Schizophrenia, Psychosis, or Rtms. Participants receive 3 Minute iTBS to the L DLPFC or Precision Brain Stimulation for Cannabis Users with Healthy Controls and complete study visits and assessments.